4 December 2017Americas

Tech companies have their say on Allergan-tribe deal at PTAB

The Computer & Communications Industry Association (CCIA) and the Association for Accessible Medicines (AAM) have urged the Patent Trial and Appeal Board (PTAB) to dismiss a Native American tribe’s attempt to shut down a series of inter partes reviews (IPRs).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
26 September 2017   The Saint Regis Mohawk Tribe has attempted to dismiss inter partes reviews brought by Mylan.
Americas
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.

More on this story

Americas
26 September 2017   The Saint Regis Mohawk Tribe has attempted to dismiss inter partes reviews brought by Mylan.
Americas
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.

More on this story

Americas
26 September 2017   The Saint Regis Mohawk Tribe has attempted to dismiss inter partes reviews brought by Mylan.
Americas
24 October 2017   The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity.